Prevalence of Sarcomere Protein Gene Mutations in Preadolescent Children With Hypertrophic Cardiomyopathy

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Circulation: Cardiovascular Genetics

• Publication date

  2008-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCGENETICS.108.821314PMID 20031618
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypertrophic cardiomyopathy in childhood.

  2010cited by this paper
• Shared genetic causes of cardiac hypertrophy in children and adults.

  2008cited by this paper
• Epidemiology and Cause-Specific Outcome of Hypertrophic Cardiomyopathy in Children: Findings From the Pediatric Cardiomyopathy Registry

  2007cited by this paper
• Myozenin 2 Is a Novel Gene for Human Hypertrophic Cardiomyopathy

  2007cited by this paper
• Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

  2007cited by this paper
• B-type natriuretic peptide predicts disease severity in children with hypertrophic cardiomyopathy

  2007cited by this paper
• Clinical Features and Outcomes of Childhood Dilated Cardiomyopathy: Results From a National Population-Based Study

  2005cited by this paper
• Molecular and phenotypic effects of heterozygous, homozygous, and compound heterozygote myosin heavy-chain mutations.

  2005cited by this paper
• Glycogen storage diseases presenting as hypertrophic cardiomyopathy.

  2005cited by this paper
• The genetic basis for cardiac remodeling.

  2005cited by this paper
• Danon Disease as an Underrecognized Cause of Hypertrophic Cardiomyopathy in Children

  2005cited by this paper
• Clinical Features and Outcomes of Childhood Hypertrophic Cardiomyopathy: Results From a National Population-Based Study

  2005cited by this paper
• Hypertrophic cardiomyopathy in childhood.

  2004cited by this paper
• Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy

  2003cited by this paper
• Expert consensus document American College of Cardiology / European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy

  2003cited by this paper
• American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G

  2003cited by this paper
• PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity.

  2002cited by this paper
• Sarcomere Protein Gene Mutations in Hypertrophic Cardiomyopathy of the Elderly

  2002cited by this paper
• The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms.

  2001cited by this paper
• The molecular genetic basis for hypertrophic cardiomyopathy.

  2001cited by this paper
• NPS@: network protein sequence analysis.

  2000cited by this paper
• Homozygotes for a R869G mutation in the beta -myosin heavy chain gene have a severe form of familial hypertrophic cardiomyopathy.

  2000cited by this paper
• Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene.

  1999cited by this paper
• Double heterozygosity for mutations in the β-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy

  1999cited by this paper
• Molecular Genetic Basis of Hypertrophic Cardiomyopathy:

  1998cited by this paper
• A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated β-myosin heavy chain genes

  1998cited by this paper
• Clinical approach to genetic cardiomyopathy in children.

  1996cited by this paper
• Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

  1996cited by this paper
• [Normal values of 2-dimensional echocardiographic parameters in children].

  1992cited by this paper
• Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy.

  1986cited by this paper

• Cryo-ET reveals nanoscale thick filament disorganization in MYH7 P710R hypertrophic cardiomyopathy cardiomyocytes

  2026cites this paper
• Mavacamten inhibits myosin activity by stabilising the myosin interacting-heads motif and stalling motor force generation

  2025cites this paper
• Cardiovascular Health and Outcomes in Carriers With Genetic Variants of Hypertrophic Cardiomyopathy.

  2025cites this paper
• The Future of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas9 Gene Therapy in Cardiomyopathies: A Review of Its Therapeutic Potential and Emerging Applications

  2025cites this paper
• Human induced pluripotent stem cell-derived cardiomyocytes for disease modeling and drug discovery

  2025cites this paper
• Troponin I – a comprehensive review of its function, structure, evolution, and role in muscle diseases

  2025cites this paper
• The G256E HCM mutation prolongs cardiac muscle relaxation via altered nucleotide handling

  2025cites this paper
• Sex Differences in Children and Adolescents With Hypertrophic Cardiomyopathy

  2025cites this paper
• AAV9-mediated MYBPC3 gene therapy with optimized expression cassette enhances cardiac function and survival in MYBPC3 cardiomyopathy models

  2025cites this paper
• A Case Study Identified a New Mutation in the TTN Gene for Inherited Hypertrophic Cardiomyopathy

  2025cites this paper
• The Role of Nt-Pro-Bnp in Predicting Outcome in Pediatric Hypertrophic Cardiomyopathy

  2024cites this paper
• YAP dysregulation triggers hypertrophy by CCN2 secretion and TGFβ uptake in human pluripotent stem cell-derived cardiomyocytes

  2024cites this paper
• Duality in disease: How two amino acid substitutions at actin residue 312 result in opposing forms of cardiomyopathy

  2024cites this paper
• A MYH7 variant in a five-generation-family with hypertrophic cardiomyopathy

  2024cites this paper
• Cryo-EM structures of cardiac muscle α-actin mutants M305L and A331P give insights into the structural mechanisms of hypertrophic cardiomyopathy

  2024cites this paper
• Current RNA strategies in treating cardiovascular diseases

  2024cites this paper
• Pediatric cardiomyopathy illustrates the importance of reinterpreting the significance of genetic variants

  2024cites this paper
• Contemporary review on pediatric hypertrophic cardiomyopathy: insights into detection and management

  2024cites this paper
• Twin Phenomena of Hypertrophic Cardiomyopathy: A Reported Case Series

  2024cites this paper
• Incomplete-penetrant hypertrophic cardiomyopathy MYH7 G256E mutation causes hypercontractility and elevated mitochondrial respiration

  2024cites this paper
• Allele-Specific Suppression of Variant MHC With High-Precision RNA Nuclease CRISPR-Cas13d Prevents Hypertrophic Cardiomyopathy

  2024cites this paper
• Exploring the Super-Relaxed State of Human Cardiac β-Myosin by Molecular Dynamics Simulations.

  2024cites this paper
• PROGNOSTIC ROLE OF NEUROHUMORAL AND EPIGENETIC MARKERS IN THE FORMATION OF PHENOTYPIC MANIFESTATIONS OF HYPERTROPHIC CARDIOMYOPATHY

  2024cites this paper
• Burden of rare genetic disorders in India: twenty-two years’ experience of a tertiary centre

  2024cites this paper
• Genetic testing and counseling for hypertrophic cardiomyopathy: An evidence‐based practice resource of the National Society of Genetic Counselors

  2024cites this paper
• Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry

  2024cites this paper
• Childhood Hypertrophic Cardiomyopathy Caused by Beta-Myosin Heavy Chain Variants Is Associated With a More Obstructive but Less Arrhythmogenic Phenotype Than Myosin-Binding Protein C Disease.

  2023cites this paper
• Multi-scale models reveal hypertrophic cardiomyopathy MYH7 G256E mutation drives hypercontractility and elevated mitochondrial respiration

  2023cites this paper
• Mechanisms of Pathogenicity of Hypertrophic Cardiomyopathy-Associated Troponin T (TNNT2) Variant R278C+/− During Development

  2023cites this paper
• Cardiomyopathies in Children: An overview.

  2023cites this paper
• Indications and management of implantable cardioverter-defibrillator therapy in childhood hypertrophic cardiomyopathy.

  2023cites this paper
• Actin's C‐terminus coordinates actin structural changes and functions

  2023cites this paper
• Study of Clinical Profile of HCM Patients Carrying 25 BP Deletion in Intron 32 of Cardiac Myosin Binding Protein C (MYBPC3) Gene

  2023cites this paper
• Familial Hypertrophic Cardiomyopathy: Diagnosis and Management

  2023cites this paper
• Clinical and Genetic Screening for Hypertrophic Cardiomyopathy in Paediatric Relatives: Changing Paradigms in Clinical Practice

  2023cites this paper
• Cryo-EM structure of the folded-back state of human β-cardiac myosin

  2023cites this paper
• 2023 ESC Guidelines for the management of cardiomyopathies.

  2023cites this paper
• Cryo-EM structure of the folded-back state of human β-cardiac myosin

  2023cites this paper
• Advanced searching for hypertrophic cardiomyopathy heritability in real practice tomorrow

  2023cites this paper
• Family Screening in Gene-Elusive Hypertrophic Cardiomyopathy: Time for a Change or Should We Tread Cautiously?

  2023cites this paper
• Whole-Exome Sequencing Reveals Mutational Signature of Hypertrophic Cardiomyopathy

  2023cites this paper
• Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies

  2022cites this paper
• The Risk of Sudden Death in Children with Hypertrophic Cardiomyopathy.

  2022cites this paper
• MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations

  2022cites this paper
• Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy

  2022cites this paper
• A gradient of force generation at rest differentiates cardiomyopathy outcomes with variants of actin located at the same residue

  2022cites this paper
• Family screening of hypertrophic cardiomyopathy in children: a case report

  2022cites this paper
• Cardiomyopathies in Children and Systemic Disorders When Is It Useful to Look beyond the Heart?

  2022cites this paper
• Diagnosis and management of rare cardiomyopathies in adult and paediatric patients.

  2022cites this paper
• The mechanics of the heart: zooming in on hypertrophic cardiomyopathy and cMyBP‐C

  2022cites this paper
• Mutation of the MYL3 gene in a patient with mid-ventricular obstructive hypertrophic cardiomyopathy

  2022cites this paper
• Diagnostic validity and clinical utility of genetic testing for hypertrophic cardiomyopathy: a systematic review and meta-analysis

  2022cites this paper
• The genetic architecture of pediatric cardiomyopathy.

  2022cites this paper
• Thin filament cardiomyopathies: A review of genetics, disease mechanisms, and emerging therapeutics

  2022cites this paper
• Cardiomyocyte Dysfunction in Inherited Cardiomyopathies

  2021cites this paper
• Genetic Cardiomyopathies: The Lesson Learned from hiPSCs

  2021cites this paper
• Childhood-onset hypertrophic cardiomyopathy research coming of age.

  2021cites this paper
• Prevention of sudden cardiac death in childhood-onset hypertrophic cardiomyopathy

  2021cites this paper
• Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy

  2021influential citation
• Cardiac myosin binding protein-C variants in paediatric-onset hypertrophic cardiomyopathy: natural history and clinical outcomes

  2021cites this paper
• Clinical presentation and long‐term outcomes of infantile hypertrophic cardiomyopathy: a European multicentre study

  2021cites this paper
• The clinical utility of pediatric cardiomyopathy genetic testing: From diagnosis to a precision medicine-based approach to care.

  2021cites this paper
• Molecular genetic features of the development of restrictive cardiomyopathy in Russian children

  2021cites this paper
• The Time Has Come to Explore Plasma Biomarkers in Genetic Cardiomyopathies

  2021cites this paper
• Genetic Restrictive Cardiomyopathy: Causes and Consequences—An Integrative Approach

  2021cites this paper
• Childhood Hypertrophic Cardiomyopathy: A Disease of the Cardiac Sarcomere

  2021cites this paper
• Whole-exome sequencing reveals MYH7 p.R671C mutation in three different phenotypes of familial hypertrophic cardiomyopathy

  2021cites this paper
• Genetic Causes of Cardiomyopathy in Children: First Results From the Pediatric Cardiomyopathy Genes Study

  2021cites this paper
• Transition et cardiomyopathies familiales

  2021cites this paper
• Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy

  2021cites this paper
• Genetics of Cardiomyopathy: Clinical and Mechanistic Implications for Heart Failure

  2021cites this paper
• The genetic basis of sudden death in young people - cardiac and non-cardiac.

  2021cites this paper
• Septal myectomy in the era of genetic testing

  2021cites this paper
• Prognostic implications of troponin T variations in inherited cardiomyopathies using systems biology

  2021cites this paper
• Pathogenic Intronic Splice-Affecting Variants in MYBPC3 in Three Patients with Hypertrophic Cardiomyopathy

  2021cites this paper
• Infantile restrictive cardiomyopathy: cTnI-R170G/W impair the interplay of sarcomeric proteins and the integrity of thin filaments

  2020cites this paper
• Multidisciplinary evaluation and management of obstructive hypertrophic cardiomyopathy in 2020: Towards the HCM Heart Team.

  2020cites this paper
• Insertional vs Targeted Mutagenesis in the Development of Zebrafish as an In Vivo Model for Cardiomyopathy

  2020influential citation
• Ablation of the N terminus of cardiac essential light chain promotes the super‐relaxed state of myosin and counteracts hypercontractility in hypertrophic cardiomyopathy mutant mice

  2020cites this paper
• Heart Failure as a Consequence of Hypertrophic Cardiomyopathy

  2020cites this paper
• The Impact of Ethnicity on Cardiac Adaptation.

  2020cites this paper
• Genetic study of pediatric hypertrophic cardiomyopathy in Egypt

  2020cites this paper
• High-Resolution Cryo-EM Structure of the Cardiac Actomyosin Complex.

  2020cites this paper
• MYL6B drives the capabilities of proliferation, invasion, and migration in rectal adenocarcinoma through the EMT process

  2020cites this paper
• Cardiomyopathies in children: classification, diagnosis and treatment.

  2020cites this paper
• Cardiomyopathies in children: classification, diagnosis and treatment.

  2020cites this paper
• Yield of Rare Variants Detected by Targeted Next-Generation Sequencing in a Cohort of Romanian Index Patients with Hypertrophic Cardiomyopathy

  2020cites this paper
• Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state

  2020cites this paper
• A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy

  2020cites this paper
• Myosins: Driving us towards novel targets and biomarkers in cancer.

  2020cites this paper
• Hereditary Hypertrophic Cardiomyopathy in Children and Young Adults—The Value of Reevaluating and Expanding Gene Panel Analyses

  2020cites this paper
• From Hypertrophy to Heart Failure: What Is New in Genetic Cardiomyopathies

  2019cites this paper
• Aspects of paediatric cardiovascular pathology

  2019cites this paper
• Factors influencing outcome in patients with obstructive hypertrophic cardiomyopathy - Effects of pharmacotherapy, pacing and surgical myectomy

  2019cites this paper
• RIKADA Study Reveals Risk Factors in Pediatric Primary Cardiomyopathy

  2019cites this paper
• Neonatal cardiac hypertrophy: the role of hyperinsulinism—a review of literature

  2019cites this paper
• Pathology of Heart Disease in the Fetus, Infant and Child

  2019cites this paper
• Diagnosing and Managing Pulmonary and Right-Sided Heart Disease: Pulmonary Hypertension, Right Ventricular Outflow Pathology, and Sleep Apnea

  2019cites this paper
• Myosin motor domains carrying mutations implicated in early or late onset hypertrophic cardiomyopathy have similar properties

  2019influential citation
• Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement From the American Heart Association.

  2019cites this paper